Xin Lang Cai Jing·2025-09-24 03:04Core Viewpoint - Spring Medical has shown significant stock price growth this year, with an increase of 87.83% year-to-date, indicating strong market performance and investor interest [2]. Company Overview - Spring Medical, established on February 12, 1998, and listed on December 30, 2021, is based in Tongzhou District, Beijing. The company specializes in the research, production, and sales of implantable orthopedic medical devices, primarily joint prosthetics and spinal implants [2]. - The company's main products include hip, knee, shoulder, and elbow joint prosthetics, as well as a full range of spinal internal fixation systems. Its products are exported to various regions, including Asia, South America, Africa, Oceania, and Europe [2]. - The revenue composition of Spring Medical is predominantly from medical device products (99.89%), with a minor contribution from other sources (0.11%) [2]. Financial Performance - As of June 30, 2025, Spring Medical reported a revenue of 488 million yuan, reflecting a year-on-year growth of 28.27%. The net profit attributable to shareholders was 114 million yuan, marking a 44.85% increase compared to the previous year [3]. - The company has distributed a total of 359 million yuan in dividends since its A-share listing, with 309 million yuan distributed over the past three years [4]. Shareholder Information - As of June 30, 2025, the number of shareholders decreased by 17.57% to 5,920, while the average number of circulating shares per person increased by 341.41% to 48,836 shares [3]. - Among the top ten circulating shareholders, Ping An Low Carbon Economy Mixed A (009878) is the fourth largest, holding 3.77 million shares, an increase of 2.77 million shares from the previous period. Southern Medical Health Flexible Allocation Mixed A (000452) is a new entrant in the ninth position, holding 1.603 million shares [4].